FIELD: medicine.
SUBSTANCE: invention relates to medicine, to medications, which can be used in addictology and psychiatry while carrying out chemotherapy. Invention concerns using of lithium ascorbate LiC6H7O6·nH2O as haematoprotecting medication and allows to extend arsenal of medications for treatment and prevention of alcoholic dependence.
EFFECT: has high haematoprotecting activity with respect to haemolysis of red cells under alcohol influence and lower toxicity than other preparations based on lithium.
1 dwg
Title | Year | Author | Number |
---|---|---|---|
AGENT WHICH INCREASES ERYTHROCYTE RESISTANCE TO HAEMOLYSIS INDUCED BY ETHANOL | 2018 |
|
RU2699224C1 |
MEANS FOR PROTECTING BLOOD PLASMA BIOMOLECULE FROM ETHANOL IMPACT | 2016 |
|
RU2618394C1 |
METHOD FOR PREVENTING BIOLOGICAL MEMBRANE DAMAGES | 2013 |
|
RU2549449C2 |
APPLICATION OF LITHIUM ASCORBATE FOR PREVENTION AND TREATMENT OF CHRONIC ALCOHOLIC INTOXICATION | 2017 |
|
RU2639496C1 |
MEANS WITH ANTISTRESS, ANXIOLYTIC AND ANTIDEPRESSANT ACTIVITY AND COMPOSITION BASED THEREON | 2015 |
|
RU2617512C1 |
AGENT FOR ENHANCEMENT OF ACTIVITY OF NEUTROPHILES | 2002 |
|
RU2226391C2 |
AGENT POSSESSING CYTOPROTECTIVE ACTION | 2019 |
|
RU2717343C1 |
MEMBRANE-PROTECTIVE PREPARATION | 2013 |
|
RU2538803C1 |
IMMUNOSTIMULATING AND ANTIOXIDANT COMPOSITION | 2008 |
|
RU2372081C1 |
METHOD FOR MEMORY IMPROVEMENT | 2016 |
|
RU2614737C1 |
Authors
Dates
2009-04-10—Published
2006-03-09—Filed